Regulatory Issues

Study Finds Federal Scientific Data Often Flawed When Not Reviewed

Published in Medical Letter on the CDC and FDA, February 14th, 2000

Independent review of U.S. funded research is crucial both for good science and for good public policy, according to the authors of a Cato Institute study.

Michael Gough and Steven Milloy argue that Public Law 105-277, known as the Shelby Amendment and enacted by Congress in October 1998, is the best way to ensure that regulatory law is based upon sound science.

The authors wrote that federally funded research has frequently been tainted by poor methodology, dubious analysis, faulty data, politicized conclusions, and even borderline cases of fraud. The law, which has been under attack, guarantees, through the provisions of the Freedom of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-02-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry